Page last updated: 2024-08-21

dihydroergotamine and 4-iodo-2,5-dimethoxyphenylisopropylamine

dihydroergotamine has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Etienne, N; Guesnier, L; Hickel, P; Maroteaux, L; Schaerlinger, B	1

Other Studies

1 other study(ies) available for dihydroergotamine and 4-iodo-2,5-dimethoxyphenylisopropylamine

Article	Year
Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy. British journal of pharmacology, 2003, Volume: 140, Issue:2 Topics: Amphetamines; Animals; Binding, Competitive; Cell Line; Cyclic GMP; Dihydroergotamine; Humans; Inositol Phosphates; Iodine Radioisotopes; Kinetics; Migraine Disorders; Radioligand Assay; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Time Factors; Treatment Outcome	2003

Article

Year

Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy.

British journal of pharmacology, 2003, Volume: 140, Issue:2

Topics: Amphetamines; Animals; Binding, Competitive; Cell Line; Cyclic GMP; Dihydroergotamine; Humans; Inositol Phosphates; Iodine Radioisotopes; Kinetics; Migraine Disorders; Radioligand Assay; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Time Factors; Treatment Outcome

2003